Elizabeth Barrett
President, CEO & Director
Good morning, everyone. Hi. I’m Liz Barrett, and I’m the CEO of UroGen Pharma. Thank you for joining us today. We’re here in Washington, D.C. at the AUA. Very excited to be here, a very exciting time for our company. I’m going to talk to you a little bit through the agenda today, and then we have an exciting agenda for you, and then there’ll be an opportunity for Q&A at the end.
So of course, our normal disclaimers here. I won’t read them. Thank goodness. We won’t have time for that. We wouldn’t have time for anything else. The agenda, I’m exciting after I’m going to make a few opening remarks, show you a few slides. I’m going to turn it over to Dr. Schoenberg and he’s going to moderate a panel discussion with our esteemed urologists. You’ll be excited to hear from them. All of them have had experience with ZUSDURI, and we’re very excited about that. But more importantly, actually, I have the opportunity to interview and share with you a story of a patient who has received ZUSDURI and recently received a complete response. So I’m very excited about that, and I think you’ll enjoy it. And then again, as I said, we’ll have an opportunity for Q&A.
